secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001104659-24-059656
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CEO Joseph Ciaffoni steps down; Chairman Michael Heffernan named Interim CEO
----------------------------------------------------------------------------

- Joseph Ciaffoni to step down as President and CEO effective May 24, 2024.
- Ciaffoni will not stand for re-election to the Board at May 16 Annual Meeting; Board reduced from nine to eight.
- Michael Heffernan, current Chairman, appointed Interim President and CEO effective May 24, 2024.
- Heffernan to receive base salary at $291,666 annual rate (one-third of Ciaffoni's salary).
- Board has initiated a search for a permanent President and CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465924059656/0001104659-24-059656-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465924059656/tm2414016d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-059656

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer